Alliancebernstein L.P. Kura Oncology, Inc. Transaction History

Alliancebernstein L.P.

$261 Billion
Q1 2025

A detailed history of Alliancebernstein L.P. transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 84,800 shares of KURA stock, worth $550,352. This represents 0.0% of its overall portfolio holdings.

Number of Shares

84,800

Previous 84,800 -0.0%

Holding current value

$550,352

Previous $738,000 24.25%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$13.42 - $23.53 $63,074 - $110,591	4,700 Added 5.87%	84,800 $1.81 Million
Q3 2023 Nov 14, 2023	SELL	$8.44 - $11.86 $1.06 Million - $1.48 Million	-125,000 Reduced 60.95%	80,100 $730,000
Q2 2023 Aug 15, 2023	BUY	$9.62 - $13.99 $1.2 Million - $1.75 Million	125,000 Added 156.05%	205,100 $2.17 Million
Q4 2022 Feb 14, 2023	SELL	$11.23 - $16.9 $1.88 Million - $2.83 Million	-167,245 Reduced 67.62%	80,100 $994,000
Q3 2022 Nov 15, 2022	BUY	$12.01 - $19.45 $1.15 Million - $1.86 Million	95,712 Added 63.12%	247,345 $3.38 Million
Q2 2022 Aug 15, 2022	SELL	$10.71 - $18.33 $708,123 - $1.21 Million	-66,118 Reduced 30.36%	151,633 $2.78 Million
Q1 2022 May 13, 2022	BUY	$11.78 - $16.98 $1.62 Million - $2.34 Million	137,851 Added 172.53%	217,751 $3.5 Million
Q2 2021 Jul 30, 2021	SELL	$20.85 - $29.88 $834,375 - $1.2 Million	-40,018 Reduced 33.37%	79,900 $1.67 Million
Q1 2021 May 06, 2021	BUY	$24.75 - $39.14 $1.02 Million - $1.61 Million	41,218 Added 52.37%	119,918 $3.39 Million
Q4 2020 Feb 08, 2021	BUY	$29.0 - $41.62 $377,000 - $541,060	13,000 Added 19.79%	78,700 $2.57 Million
Q3 2020 Nov 12, 2020	SELL	$16.3 - $30.64 $30,970 - $58,216	-1,900 Reduced 2.81%	65,700 $2.01 Million
Q2 2020 Aug 13, 2020	BUY	$7.95 - $18.81 $237,705 - $562,419	29,900 Added 79.31%	67,600 $1.1 Million
Q1 2020 May 14, 2020	BUY	$6.45 - $14.04 $65,145 - $141,804	10,100 Added 36.59%	37,700 $375,000
Q2 2019 Aug 14, 2019	BUY	$14.71 - $19.79 $27,949 - $37,601	1,900 Added 7.39%	27,600 $543,000
Q1 2019 May 14, 2019	SELL	$13.73 - $16.87 $12,357 - $15,183	-900 Reduced 3.38%	25,700 $426,000
Q4 2018 Feb 13, 2019	BUY	$10.6 - $17.49 $41,340 - $68,211	3,900 Added 17.18%	26,600 $373,000
Q3 2018 Nov 08, 2018	BUY	$16.65 - $21.85 $98,234 - $128,915	5,900 Added 35.12%	22,700 $397,000
Q2 2018 Aug 13, 2018	BUY	$14.8 - $18.8 $79,920 - $101,520	5,400 Added 47.37%	16,800 $306,000
Q1 2018 May 14, 2018	BUY	$14.5 - $23.4 $165,300 - $266,760	11,400 New	11,400 $214,000

Others Institutions Holding KURA

# of Institutions

190

Shares Held

79M

Call Options Held

76K

Put Options Held

85.8K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $434M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Kura Oncology, Inc. Transaction History